Player FM - Internet Radio Done Right
119 subscribers
Checked 5d ago
yedi yıl önce eklendi
İçerik Robert Pass tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Robert Pass veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Player FM - Podcast Uygulaması
Player FM uygulamasıyla çevrimdışı Player FM !
Player FM uygulamasıyla çevrimdışı Player FM !
Pediheart Podcast #238: Outcomes of Non-Cardiac Surgery In The ACHD Patient + A Conversation With Dr. Alexandra Lansky Of JSCAI
Manage episode 353641967 series 2087001
İçerik Robert Pass tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Robert Pass veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
This week we delve into the world of ACHD when we review a recent work on outcomes of non-cardiac surgery in the ACHD patient. How do ACHD patients fare in comparison to their non-ACHD cohort undergoing non-cardiac surgery? What can be done to improve outcomes in this patient group? We speak with the senior author of this work, Dr. Peyman Benharash, who is Associate Professor of Surgery at UCLA. DOI: 10.1136/heartjnl-2022-321512
Also joining us this week is Dr. Alexandra Lansky of Yale University who is also the Editor-in-Chief of JSCAI which is the newest interventional cardiology journal and the official journal of SCAI. Dr. Lansky shares with us her hopes for the new journal and also the role that congenital interventions will play in this journal. Visit JSCAI.org to see what 'all the fuss' is about!
…
continue reading
Also joining us this week is Dr. Alexandra Lansky of Yale University who is also the Editor-in-Chief of JSCAI which is the newest interventional cardiology journal and the official journal of SCAI. Dr. Lansky shares with us her hopes for the new journal and also the role that congenital interventions will play in this journal. Visit JSCAI.org to see what 'all the fuss' is about!
488 bölüm
Manage episode 353641967 series 2087001
İçerik Robert Pass tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Robert Pass veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
This week we delve into the world of ACHD when we review a recent work on outcomes of non-cardiac surgery in the ACHD patient. How do ACHD patients fare in comparison to their non-ACHD cohort undergoing non-cardiac surgery? What can be done to improve outcomes in this patient group? We speak with the senior author of this work, Dr. Peyman Benharash, who is Associate Professor of Surgery at UCLA. DOI: 10.1136/heartjnl-2022-321512
Also joining us this week is Dr. Alexandra Lansky of Yale University who is also the Editor-in-Chief of JSCAI which is the newest interventional cardiology journal and the official journal of SCAI. Dr. Lansky shares with us her hopes for the new journal and also the role that congenital interventions will play in this journal. Visit JSCAI.org to see what 'all the fuss' is about!
…
continue reading
Also joining us this week is Dr. Alexandra Lansky of Yale University who is also the Editor-in-Chief of JSCAI which is the newest interventional cardiology journal and the official journal of SCAI. Dr. Lansky shares with us her hopes for the new journal and also the role that congenital interventions will play in this journal. Visit JSCAI.org to see what 'all the fuss' is about!
488 bölüm
Tüm bölümler
×1 Pediheart Podcast #327: Long-Term Outcomes Of The Ross Procedure In The Newborn And Infant 33:51
33:51
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
33:51This week we delve into the world of cardiovascular surgery when we review a recent multicenter ("Ross Collaborative") study of long term outcomes of the Ross procedure in newborns and infants. How durable of a repair is this in this young age range? How does the neo-aortic root grow with time? Why might the neo-aorta not dilate in this age group as much as is reported in older patients following the Ross procedure? Who is a candidate for this approach? How are decisions made between aortic valve repair and Ross procedure? Professor David Winlaw who is director of cardiovascular surgery at Lurie Children's Hospital/Northwestern University joins the podcast this week to discuss the results of this multicenter work on this topic of which he is the senior author. DOI: 10.1016/j.jtcvs.2024.06.030…
1 Pediheart Podcast #326: Do All Infants With SVT Require Medical Therapy? 31:20
31:20
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
31:20This week we review a recent report that asks the question, 'Do all infants who present with SVT require preventive anti-arrhythmic medical therapy?' Who might be a candidate for not using an anti-arrhythmia medication in infancy? What sort of parental education is needed to potentially not use medicine and how do patients not treated compare to those who were treated with anti-arrhythmics in regards to re-admission or presentation to the emergency department or development of tachycardia induced cardiomyopathy? How should parents assess their infants for SVT at home? How long should infants be monitored prior to discharge to home after a single uncomplicated episode of SVT? We speak with Assistant Professor of Pediatrics at Washington University and the first author of this week's work, Dr. Anthony Pompa. DOI: 10.1007/s00246-023-03263-1…
1 Pediheart Podcast #325: Cardiovascular Outcomes In The HLHS Fontan Patient Versus Other Single RV Fontan Patients 23:02
23:02
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
23:02This week we review a recent large scale, multicenter adult congenital heart study on outcomes of HLHS Fontan patients versus other single RV Fontan patients. How do the two groups compare in regards to thromboembolic risk, risk for arrhythmia or risk for death and heart transplantation? Why might there be differences between these single RV patient groups? How can these results inform management? We speak with Assistant Professor of Medicine and Pediatrics at The Icahn School of Medicine at Mount Sinai, ACHD expert Dr. Kali Hopkins. doi: 10.1161/JAHA.124.034757. Epub 2024 Nov 27…
1 Pediheart Podcast #324: When It Comes To Retirement How Much Is Enough With Mr. Paul Merriman 50:03
50:03
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
50:03This week to conclude 2024 we speak with noted investment expert Mr. Paul Merriman to discuss a few topics related to personal finance and investing. First we tackle the notion of having 'enough' to retire. Is there a magic value and how would one think about this? Why is an S&P 500 Index or Total US Stock Market Index a fine 'core' investment and how might one possibly improve upon its performance? What are some of the psychological hurdles we have as investors and potential retirees? Mr. Merriman reviews these and other topics on our end of year episode. Wishing all a happy and healthy new year to you and your families and loved ones. Paul Merriman's Website: https://www.paulmerriman.com Paul's "Quilt" Chart: https://www.paulmerriman.com/12-hidden-lessons-from-investment-history#gsc.tab=0 Paul's "Bootcamp" page: https://www.paulmerriman.com/bootcamp Last Year's episode of Pediheart was replayed on Mr. Merriman's site: https://www.paulmerriman.com/pediheart-podcast-279-asset-allocation-in-your-retirement-accounts#gsc.tab=0 Paul's book "We're Talking Millions": https://www.paulmerriman.com/free-books#gsc.tab=0…
1 Pediheart Podcast Replay of #203: A Conversation With Dr. Michael Freed 54:42
54:42
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
54:42This week we replay episode #203 with Professor Michael Freed of Harvard University, who died this past week. In this episode from 2022 we review his seminal paper on prostaglandin for the treatment of infants with critical congenital heart disease from 1981 and then speak with Dr. Freed about his life, career, the development of PGE1 and more in this wide-ranging interview with this pediatric cardiology pioneer. Dr. Freed shares important career advice as he would to cardiology fellows during his long and illustrious career, advising and shaping the careers of pediatric cardiologists for 5 decades. doi: 10.1161/01.cir.64.5.899.…
1 Pediheart Podcast #323: The Evolving Role And Meaning Of Family History For The Prevention Of Cardiovascular Disease 34:31
34:31
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
34:31This week we delve into preventive cardiology with noted world authority, Associate Professor of Pediatrics, Dr. Carissa M. Baker-Smith of Nemours Health. In the present era, what roles do environment and social determinants of health play in cardiovascular disease? How should practitioners take a family history and how has the family history evolved in modern times? How can clinicians be sure that they are not ' missing ' factors when they are trying to screen for cardiovascular disease risk in their patients? What are a few practical changes in how we speak with patients that we can all make to improve our understanding of our patients and their families? An important conversation this week with Dr. Baker-Smith. https://doi.org/10.1007/s11883-024-01232-4…
1 Pediheart Podcast #322: Hepatocellular Carcinoma And The Fontan Operation 26:34
26:34
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
26:34This week we delve into the world of adult congenital heart disease to review the topic of liver disease in the Fontan patient and specifically, hepatocellular carcinoma (HCC). What is the prevalence of this disease in the Fontan single ventricle adult patient? How effective are scores like the MELD-XI or Fibrosis-4 Index at identification of HCC in the Fontan patient? How should the Fontan adult patient be surveilled for this form of cancer? What evidence is there that earlier identification of HCC is associated with better outcomes? What may prove to be the most important factor in protection of the liver in the Fontan patient? Dr. Yuli Kim, Director of the ACHD program at The University of Pennsylvania shares her deep insights this week into this important topic. DOI: 10.1093/eurheartj/ehad788…
1 Pediheart Podcast #321: A Tribute To Interventional Cardiology Pioneer And Mentor, Professor Chuck Mullins 51:53
51:53
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
51:53This week we celebrate the life and career of Dr. Charles Mullins who passed this past week. Dr. Mullins was Professor of Pediatrics at Baylor College of Medicine and one of the pioneers in the world of congenital heart interventional cardiology. In today's episode we will listen back to an episode from 2021 from the SCAI 2021 meeting in which we interviewed Dr. Mullins and Dr. Julie Vincent (then Professor of Pediatrics at Columbia University). Drs. Mullins and Vincent discuss their lives as interventional cardiologists and also speak about the role that mentorship played in their long careers. Dr. Aimee Armstrong of Nationwide Children's Hospital also participates in this conversation. Following this interview replay with Drs. Mullins and Vincent, we speak with Dr. Frank Ing who is the Director of Pediatric Cardiology at UC Davis and the former director of the catheterization lab at Texas Children's and a former trainee and close friend of Dr. Mullins and his family. Dr. Ing shares his memories of training under Dr. Mullins, his thoughts on what was possibly Dr. Mullins' greatest professional contribution and finally speaks about what he learned about being a good mentor from his years with Dr. Mullins.…
1 Pediheart Podcast #320: The Extraordinary Life Of Professor Helen Taussig With Author Patricia Meisol 38:44
38:44
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
38:44This week we speak for the entire episode with award winning author Patricia Meisol about her recent book entitled: A Heart Afire: Helen Brooke Taussig's Battle Against Heart Defects, Unsafe Drugs, and Injustice in Medicine . We review Dr. Taussig's early life and the impact it had on her life. Why was there friction between Drs. Taussig and Blalock? What was Dr. Taussig's role in the establishment of the most stringent drug testing rules in the world today? What would Dr. Taussig consider to be her greatest achievement? Was Dr. Taussig the first in our field to understand the notion of social determinants of health? Ms. Meisol reviews this and more in our wide ranging conversation about the extraordinary Professor Helen Taussig. We also share a brief conversation of Dr. Taussig from 1977, speaking about her role in the development of the BTT shunt. For those interested, Ms. Meisel's book is available: https://bookshop.org/p/books/a-heart-afire-helen-brooke-taussigs-battle-against-heart-defects-unsafe-drugs-and-injustice-in-medicine-patricia-meisol/19955020?ean=9780262048521 or wherever you get your books!…
1 Pediheart Podcast #320: The Extraordinary Life Of Professor Helen Taussig With Author Patricia Meisol 38:44
38:44
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
38:44This week we speak for the entire episode with award winning author Patricia Meisol about her recent book entitled: A Heart Afire: Helen Brooke Taussig's Battle Against Heart Defects, Unsafe Drugs, and Injustice in Medicine . We review Dr. Taussig's early life and the impact it had on her life. Why was there friction between Drs. Taussig and Blalock? What was Dr. Taussig's role in the establishment of the most stringent drug testing rules in the world today? What would Dr. Taussig consider to be her greatest achievement? Was Dr. Taussig the first in our field to understand the notion of social determinants of health? Ms. Meisol reviews this and more in our wide ranging conversation about the extraordinary Professor Helen Taussig. We also share a brief conversation of Dr. Taussig from 1977, speaking about her role in the development of the BTT shunt. For those interested, Ms. Meisel's book is available: https://bookshop.org/p/books/a-heart-afire-helen-brooke-taussigs-battle-against-heart-defects-unsafe-drugs-and-injustice-in-medicine-patricia-meisol/19955020?ean=9780262048521 or wherever you get your books!…
1 Pediheart Podcast #319: The Rapidly Growing Role of Congenital Cardiac CT In The Present Era 35:45
35:45
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
35:45This week we enter the world of cardiac CT for congenital heart disease reviewing a recent report of a survey of congenital cardiologists who perform congenital heart CT scans. What have been the important trends seen in the past decade beyond expansion in the field in general? Why has the use of the CT scan grown at such a rapid clip? How much radiation does a present day CT scan represent for a patient? How are cardiology fellowships responding to the growing role of this modality in the field? How can we more properly assign accurate relative value units (RVU's) to the significant work effort involved in the performance and reporting of this novel modality. We speak with the first author of this week's work, Assistant Professor of Pediatrics at Weill Cornell, Dr. Rebecca Epstein. doi: 10.1016/j.jcct.2024.02.002. Epub 2024 Feb 15.…
1 Pediheart Podcast #318: Is It Time To Abolish The Insurance "Pre-Authorization" For Congenital Cardiology? 29:44
29:44
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
29:44This week we review a recent thought-provoking work on the topic of the dreaded 'pre-authorization' process for procedures being performed in the US. Are there data to support the costs in money and time associated with this process in the world of congenital cardiology? How often are authorizations denied in congenital cardiac cases? Is there any evidence that obtaining insurance pre-authorization improves outcomes? What is the impact of this process on healthcare equity? These are amongst the questions reviewed this week with Dr. Brian Marcus who is a cardiologist and critical care fellow at Children's Wisconsin. DOI: 10.1007/s00246-023-03255-1…
1 Pediheart Podcast #317: Transcatheter Pulmonary Valve Replacement After The Arterial Switch Operation 27:52
27:52
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
27:52Pulmonary valve replacement following the arterial switch operation is rare. However, when necessary, how do techniques of transcatheter valve replacement fare for this indication? Why would average outcomes in this setting be less good than in the typical TPVR tetralogy of Fallot patient? How does the presence of stents in the pulmonary arteries in this patient group affect candidacy for TPVR? Are there ways to predict who might be a candidate for a TPVR vs. surgical PVR before coming to the catheterization lab? These are amongst the questions reviewed and posed to Dr. Stephen Nageotte who is the director of the cardiac catheterization laboratory at Loma Linda Children's Hospital in Loma Linda, California. DOI: 10.1002/ccd.31152…
1 Pediheart Podcast #316: A Multicenter Study Of CPVT And Outcomes With And Without ICD Therapy 36:39
36:39
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
36:39This week we review a recent large scale study on catecholaminergic polymorphic ventricular tachycardia (CPVT) in children which is based on two large international registries. How do outcomes differ between those symptomatic CPVT patients treated with or without an ICD? Who amongst symptomatic CPVT pediatric patients likely warrant an ICD? What sort of ICD might be optimal - subcutaneous or transvenous? Are there ways to program ICD's in CPVT patients that may reduce inappropriate shocks? Why should the ICD be rarely employed in the CPVT pediatric patient? These are amongst the questions reviewed this week on the podcast. We speak with the work's senior author, Dr. Shubhayan Sanatani who is the chief of pediatric cardiology at BC Children's Hospital in Vancouver, British Columbia, Canada. doi: 10.1016/j.hrthm.2024.04.006. Epub 2024 Apr 7.…
1 Pediheart Podcast #315: Does Opioid Exposure In Infants Following CHD Surgery Impact Neurodevelopmental Outcomes? 30:10
30:10
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
30:10This week we delve into the worlds of cardiac critical care and neurodevelopment when we review a recent report from the team at Children's Hospital of Philadelphia assessing an association between postoperative opioid exposure in infants following CHD surgery and neurodevelopmental outcomes. What might be the biological basis for an association between these 2 factors? How confident can we be that opioid exposure is the factor of importance when there are so many co-variates and variables? We speak with outcomes research expert and interventional cardiologist Dr. Michael O'Byrne about this important and thought-provoking recent work. DOI: 10.1016/j.jacc.2024.06.033…
Player FM'e Hoş Geldiniz!
Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.